These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9839934)

  • 1. In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity.
    Forthal DN; Landucci G
    J Immunol Methods; 1998 Nov; 220(1-2):129-38. PubMed ID: 9839934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions.
    Forthal DN; Landucci G; Katz J; Tilles JG
    J Infect Dis; 1993 Oct; 168(4):1020-3. PubMed ID: 8376813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of measles virus infectivity and antibody-dependent cell-mediated cytotoxicity activity against an Epstein-Barr virus-infected cell line by intravenous immunoglobulin G [corrected].
    Colomar M; Puga I; López M; Massot M; Jorquera JI; Reina M; Vilaró S; Espel E
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):751-6. PubMed ID: 12965899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    Kreth HW; Meulen V
    J Immunol; 1977 Jan; 118(1):291-5. PubMed ID: 830752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles virus-specific functional antibody responses and viremia during acute measles.
    Forthal DN; Landucci G; Habis A; Zartarian M; Katz J; Tilles JG
    J Infect Dis; 1994 Jun; 169(6):1377-80. PubMed ID: 8195621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.
    Kreth HW; Wiegand G
    J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    Perrin LH; Tishon A; Oldstone MB
    J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
    Patel PC; Menezes J
    Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays.
    Chung S; Nguyen V; Lin YL; Kamen L; Song A
    J Immunol Methods; 2017 Aug; 447():37-46. PubMed ID: 28434980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.
    Chung S; Lin YL; Reed C; Ng C; Cheng ZJ; Malavasi F; Yang J; Quarmby V; Song A
    J Immunol Methods; 2014 May; 407():63-75. PubMed ID: 24704820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
    Bradley TP; Bonavida B
    Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC).
    Nelson DL; Kurman CC; Serbousek DE
    Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.27. PubMed ID: 18432838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell-mediated cytotoxicity against varicella-zoster virus-infected targets.
    Kamiya H; Starr SE; Arbeter AM; Plotkin SA
    Infect Immun; 1982 Nov; 38(2):554-7. PubMed ID: 6292106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cytotoxicity against the envelope glycoprotein of human immunodeficiency virus-1: evidence for antibody-dependent cellular cytotoxicity in vivo.
    Tanneau F; McChesney M; Lopez O; Sansonetti P; Montagnier L; Rivière Y
    J Infect Dis; 1990 Oct; 162(4):837-43. PubMed ID: 1698205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
    Kreth WH; Käckell MY; ter Meulen V
    J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cell-mediated immunity to measles virus with 51Cr release cytotoxic assay in patients with natural measles.
    Chiba S; Yamanaka T; Nakao T
    Tohoku J Exp Med; 1974 Mar; 112(3):285-8. PubMed ID: 4838069
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.
    Hicks JT; Klutch MJ; Albrecht P; Frank MM
    J Immunol; 1976 Jul; 117(1):208-15. PubMed ID: 819582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.